Back to Search
MARK VALASEK, MD PHD
MD PHD
Anatomic Pathology & Clinical Pathology Physician
NPI: 1588808448Individual
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
A127165(CA)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 2009
Research & Publications (7)
Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.
PMID 18718997·Am J Physiol Gastrointest Liver Physiol·2008
7-preclinical
Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse.
PMID 17726195·J Lipid Res·2007
7-preclinical
Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse.
PMID 18160655·J Neurosci·2007
7-preclinical
Caveolin-1 is not required for murine intestinal cholesterol transport.
PMID 15919660·J Biol Chem·2005
7-preclinical
Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease.
PMID 15835268·J Neuropathol Exp Neurol·2005
7-preclinical
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41.
PMID 14722361·Proc Natl Acad Sci U S A·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3201 UNIVERSITY DR E STE 330
BRYAN, TX 77802 - Phone
- (979) 321-6290
Quick Facts
- NPI
- 1588808448
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 7
Are you this provider?
Claim Your Profile